LLLT Combined With CDT in Breast Cancer-Related Lymphedema
The Effectiveness of Low Level Laser Therapy (LLLT)Combined With Complex Decongestive Therapy (CDT) in the Treatment of Breast Cancer-Related Lymphedema: A Double-Blind, Randomized, Placebo-Controlled Study
Sponsor: NYU Langone Health
Listed as NCT01351376, this NA trial focuses on Breast Cancer and Lymphedema and remains completed. Sponsored by NYU Langone Health, it has been updated 13 times since 2011, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Oct 2019 — Feb 2020 [monthly]
Completed NA
-
Jun 2019 — Oct 2019 [monthly]
Completed NA
-
Jun 2018 — Jun 2019 [monthly]
Completed NA
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
-
Aug 2017 — Oct 2017 [monthly]
Completed NA
-
Feb 2017 — Aug 2017 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NYU Langone Health
For direct contact, visit the study record on ClinicalTrials.gov .